Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2012, Article ID 704314, 6 pages
http://dx.doi.org/10.1155/2012/704314
Review Article

Admission Hyperglycemia and Acute Myocardial Infarction: Outcomes and Potential Therapies for Diabetics and Nondiabetics

1Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
2PERFUSE Angiographic Core Laboratories and Data Coordinating Center, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA

Received 4 August 2011; Revised 27 April 2012; Accepted 29 April 2012

Academic Editor: Chim Choy Lang

Copyright © 2012 Anjan K. Chakrabarti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Haffner, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso, “Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction,” The New England Journal of Medicine, vol. 339, no. 4, pp. 229–234, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. W. B. Kannel and D. L. McGee, “Diabetes and cardiovascular risk factors: the Framingham study,” Circulation, vol. 59, no. 1, pp. 8–13, 1979. View at Google Scholar · View at Scopus
  3. E. Selvin, S. Marinopoulos, G. Berkenblit et al., “Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus,” Annals of Internal Medicine, vol. 141, no. 6, pp. 421–431, 2004. View at Google Scholar · View at Scopus
  4. A. Shankar, R. Klein, B. E. K. Klein, and S. E. Moss, “Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes,” American Journal of Epidemiology, vol. 166, no. 4, pp. 393–402, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. H. C. Gerstein, M. C. Riddle, D. M. Kendall et al., “Glycemia treatment strategies in the action to control cardiovascular risk in diabetes (accord) trial,” American Journal of Cardiology, vol. 99, no. 12, supplement, pp. S34–S43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Kosiborod, S. E. Inzucchi, H. M. Krumholz et al., “Glucometrics in patients hospitalized with acute myocardial infarction-defining the optimal outcomes-based measure of risk,” Circulation, vol. 117, no. 8, pp. 1018–1027, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. E. Capes, D. Hunt, K. Malmberg, and H. C. Gerstein, “Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview,” The Lancet, vol. 355, no. 9206, pp. 773–778, 2000. View at Google Scholar · View at Scopus
  8. J. J. O'Sullivan, R. M. Conroy, K. Robinson, N. Hickey, and R. Mulcahy, “In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction,” Diabetes Care, vol. 14, no. 8, pp. 758–760, 1991. View at Google Scholar · View at Scopus
  9. A. M. Svensson, D. K. McGuire, P. Abrahamsson, and M. Dellborg, “Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events,” European Heart Journal, vol. 26, no. 13, pp. 1255–1261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Goyal, K. W. Mahaffey, J. Garg et al., “Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study,” European Heart Journal, vol. 27, no. 11, pp. 1289–1297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Suleiman, H. Hammerman, M. Boulos et al., “Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study,” Circulation, vol. 111, no. 6, pp. 754–760, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. R. S. Loomba and R. Arora, “Hyperglycemia and acute coronary syndrome: a systematic review of hyperglycemia's impact on ACS,” American Journal of Therapeutics, vol. 17, no. 2, pp. e48–e51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. F. Oliver and L. H. Opie, “Effects of glucose and fatty acids on myocardial ischaemia and arrhtyhmias,” The Lancet, vol. 343, no. 8890, pp. 155–158, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. J. R. Timmer, J. P. Ottervanger, M. J. De Boer et al., “Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction,” Journal of the American College of Cardiology, vol. 45, no. 7, pp. 999–1002, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Lazzeri, M. Chiostri, A. Sori, S. Valente, and G. F. Gensini, “Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement,” Journal of Cardiovascular Medicine, vol. 11, no. 1, pp. 7–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Gresele, G. Guglielmini, M. De Angelis et al., “Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with Type II diabetes mellitus,” Journal of the American College of Cardiology, vol. 41, no. 6, pp. 1013–1020, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Marfella, M. Siniscalchi, K. Esposito et al., “Effects of Stress Hyperglycemia on Acute Myocardial Infarction: role of inflammatory immune process in functional cardiac outcome,” Diabetes Care, vol. 26, no. 11, pp. 3129–3135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Esposito, F. Nappo, R. Marfella et al., “Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress,” Circulation, vol. 106, no. 16, pp. 2067–2072, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Lazzeri, S. Valente, M. Chiostri, C. Picariello, and G. F. Gensini, “In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes,” European Journal of Cardiovascular Prevention and Rehabilitation. In press. View at Publisher · View at Google Scholar
  20. F. G. Kushner, M. Hand, S. C. Smith et al., “2009 focused updates: ACC/AHA guidelines for the management of patients with st-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and acc/aha/scai guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the american college of cardiology foundation/american heart association task force on practice guidelines,” Journal of the American College of Cardiology, vol. 54, no. 23, pp. 2205–2241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. E. M. Antman, M. Hand, P. W. Armstrong et al., “2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines,” Circulation, vol. 117, no. 2, pp. 296–329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Chaudhuri, D. Janicke, M. F. Wilson et al., “Anti-inflammatory and profibrinolytic effect of insulin in acute st-segment-elevation myocardial infarction,” Circulation, vol. 109, no. 7, pp. 849–854, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. V. W. Wong, M. Mardini, N. W. Cheung, and A. S. Mihailidou, “High-dose insulin in experimental myocardial infarction in rabbits: orotection against effects of hyperglycaemia,” Journal of Diabetes and its Complications, vol. 25, no. 2, pp. 122–128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. R. Timmer, T. Svilaas, J. P. Ottervanger et al., “Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the glucose-insulin-potassium study (gips)-ii,” Journal of the American College of Cardiology, vol. 47, no. 8, pp. 1730–1731, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Malmberg, “Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus,” BMJ, vol. 314, no. 7093, pp. 1512–1515, 1997. View at Google Scholar · View at Scopus
  26. S. R. Mehta, “Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial,” JAMA, vol. 293, no. 4, pp. 437–446, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. N. W. Cheung, V. W. Wong, and M. Mclean, “The hyperglycemia: intensive insulin infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction,” Diabetes Care, vol. 29, no. 4, pp. 765–770, 2006. View at Google Scholar · View at Scopus
  28. K. Malmberg, A. Norhammar, H. Wedel, and L. Rydén, “Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study,” Circulation, vol. 99, no. 20, pp. 2626–2632, 1999. View at Google Scholar · View at Scopus
  29. K. Malmberg, L. Rydén, H. Wedel et al., “FASTTRACK intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity,” European Heart Journal, vol. 26, no. 7, pp. 650–661, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Kosiborod and P. Deedwania, “An overview of glycemic control in the coronary care unit with recommendations for clinical management,” Journal of Diabetes Science and Technology, vol. 3, no. 6, pp. 1342–1351, 2009. View at Google Scholar · View at Scopus
  31. P. Deedwania, M. Kosiborod, E. Barrett et al., “Hyperglycemia and acute coronary syndrome: a scientific statement from the american heart association diabetes committee of the council on nutrition, physical activity, and metabolism,” Circulation, vol. 117, no. 12, pp. 1610–1619, 2008. View at Publisher · View at Google Scholar · View at Scopus